Ablaze Pharmaceuticals’ US$75 Million Series A Financing

Sidley Austin advised Vivo Capital and AdvanTech Capital on the deal.Vivo Capital and AdvanTech Capital acted as lead investors in the US$75 million Series A financing…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here